Mifepristone

"Mifepristone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING SYNDROME.

Descriptor ID	D015735
MeSH Number(s)	D04.210.500.365.415.580
Concept/Terms	Mifepristone Mifepristone ZK-98296 ZK-98296 ZK 98296 ZK98296 R-38486 R-38486 R 38486 RU-486 RU 486 RU486 R38486 RU-38486 RU 38486 RU38486 Mifegyne Mifegyne Mifégyne Mifeprex Mifeprex

Below are MeSH descriptors whose meaning is more general than "Mifepristone".

Chemicals and Drugs [D]
Polycyclic Compounds [D04]
Fused-Ring Compounds [D04.210]
Steroids [D04.210.500]
Estranes [D04.210.500.365]
Estrenes [D04.210.500.365.415]
Mifepristone [D04.210.500.365.415.580]

Below are MeSH descriptors whose meaning is related to "Mifepristone".

Below are MeSH descriptors whose meaning is more specific than "Mifepristone".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Mifepristone" by people in this website by year, and whether "Mifepristone" was a major or minor topic of these publications.

Bar chart showing 20 publications over 14 distinct years, with a maximum of 4 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	0	1	1
2002	0	2	2
2003	0	1	1
2005	0	1	1
2006	0	1	1
2008	1	0	1
2010	0	1	1
2011	0	1	1
2015	0	1	1
2016	0	1	1
2019	1	0	1
2021	1	3	4
2022	0	3	3
2023	0	1	1

Below are the most recent publications written about "Mifepristone" by people in Profiles.

Koenig LR, Raymond EG, Gold M, Boraas CM, Kaneshiro B, Winikoff B, Coplon L, Upadhyay UD. Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United States. Contraception. 2023 05; 121:109962.

View in: PubMed
Pearlman Shapiro M, Dethier D, Kahili-Heede M, Kaneshiro B. No-Test Medication Abortion: A Systematic Review. Obstet Gynecol. 2023 01 01; 141(1):23-34.

View in: PubMed
Upadhyay UD, Raymond EG, Koenig LR, Coplon L, Gold M, Kaneshiro B, Boraas CM, Winikoff B. Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study. JAMA Intern Med. 2022 05 01; 182(5):482-491.

View in: PubMed
Friedlander EB, Raidoo S, Soon R, Salcedo J, Davis J, Tschann M, Fontanilla T, Horiuchi W, Kaneshiro B. The experience of pain in real-time during medication abortion. Contraception. 2022 06; 110:71-75.

View in: PubMed
Raidoo S, Kaneshiro B, Stowers P. Guam: The US territory where America's day begins but abortion access is still in the dark. Contraception. 2021 07; 104(1):33-35.

View in: PubMed
Kerestes C, Murayama S, Tyson J, Natavio M, Seamon E, Raidoo S, Lacar L, Bowen E, Soon R, Platais I, Kaneshiro B, Stowers P. Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models. Contraception. 2021 07; 104(1):49-53.

View in: PubMed
Chong E, Shochet T, Raymond E, Platais I, Anger HA, Raidoo S, Soon R, Grant MS, Haskell S, Tocce K, Baldwin MK, Boraas CM, Bednarek PH, Banks J, Coplon L, Thompson F, Priegue E, Winikoff B. Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic. Contraception. 2021 07; 104(1):43-48.

View in: PubMed
Raymond EG, Anger HA, Chong E, Haskell S, Grant M, Boraas C, Tocce K, Banks J, Kaneshiro B, Baldwin MK, Coplon L, Bednarek P, Shochet T, Platais I. "False positive" urine pregnancy test results after successful medication abortion. Contraception. 2021 06; 103(6):400-403.

View in: PubMed
Raymond E, Chong E, Winikoff B, Platais I, Mary M, Lotarevich T, Castillo PW, Kaneshiro B, Tschann M, Fontanilla T, Baldwin M, Schnyer A, Coplon L, Mathieu N, Bednarek P, Keady M, Priegue E. TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States. Contraception. 2019 09; 100(3):173-177.

View in: PubMed
Yan C, Yang H, Wang Y, Dong Y, Yu F, Wu Y, Wang W, Adaku U, Lutfy K, Friedman TC, Tian S, Liu Y. Increased glycogen synthase kinase-3? and hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to glucocorticoid-induced mouse visceral adiposity. Int J Obes (Lond). 2016 08; 40(8):1233-41.

View in: PubMed

People

Explore

Similar Concepts

Top Journals